Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

NCT00635219 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

766

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Placebo
DRUG: Vortioxetine (Lu AA21004)
DRUG: Vortioxetine (Lu AA21004)
DRUG: Vortioxetine (Lu AA21004)
DRUG: Duloxetine

Sponsor

H. Lundbeck A/S